Does clinical trial participation improve outcomes in patients with ovarian cancer?
Name:
ESMO e000057.full.pdf
Size:
590.5Kb
Format:
PDF
Description:
Full text, Open Access Article
Authors
Khoja, LeilaHorsley, Laura
Heesters, A
Machin, J D
Mitchell, Claire L
Clamp, Andrew R
Hasan, Jurjees
Jayson, Gordon C
Affiliation
The Christie NHS Foundation Trust , Manchester , UKThe Christie NHS Foundation Trust , Manchester , UKIssue Date
2016
Metadata
Show full item recordAbstract
Treatment on a clinical trial is considered to be beneficial to oncology patients. However, supportive evidence for this is scarce. Trial effect describes the phenomenon of improved health outcomes in patients treated with standard of care (SOC) on trial compared to those receiving SOC outside of a clinical trial. We evaluated trial effect in patients with ovarian cancer treated at our tertiary cancer centre.Citation
Does clinical trial participation improve outcomes in patients with ovarian cancer? 2016, 1(4):e000057 ESMO OpenJournal
ESMO openDOI
10.1136/esmoopen-2016-000057PubMed ID
27843621Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/esmoopen-2016-000057
Scopus Count
Collections
Related articles
- Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.
- Authors: Gray HJ, Benigno B, Berek J, Chang J, Mason J, Mileshkin L, Mitchell P, Moradi M, Recio FO, Michener CM, Secord AA, Tchabo NE, Chan JK, Young J, Kohrt H, Gargosky SE, Goh JC
- Issue date: 2016
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
- Authors: Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ, ICON7 trial investigators
- Issue date: 2015 Aug
- Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
- Authors: Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar MKB, Ehlen T, Jayson GC, Johnson N, Swart AM, Verheijen R, McCluggage WG, Perren T, Panici PB, Kenter G, Casado A, Mendiola C, Stuart G, Reed NS, Kehoe S, EORTC, MRC CHORUS study investigators
- Issue date: 2018 Dec
- Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
- Authors: Blank O, von Tresckow B, Monsef I, Specht L, Engert A, Skoetz N
- Issue date: 2017 Apr 27
- Age is associated with prognosis in serous ovarian carcinoma.
- Authors: Deng F, Xu X, Lv M, Ren B, Wang Y, Guo W, Feng J, Chen X
- Issue date: 2017 Jun 12